FDA Inspection
NORTHEAST BIOLABNORTHEAST BIOLAB – FDA Inspection, Jul 17, 2026
Record Details
This FDA Inspection record concerns NORTHEAST BIOLAB, with an inspection on July 17, 2026, issued by the New England District Office, covering human drugs.
View Company Profile
ID · 775ac5bb-fc0a-4837-be6b-e1e405f36024
Inspection Facts
- Inspection number
- 1326756
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 58.190(b)Archives: conditions of storage
- 21 CFR 58.33(f)Study director: transfer of data to archives
- 21 CFR 58.35(b)(7)QAU: signed statement in final report
- 21 CFR 58.81(a)SOPs: laboratory methods
- 21 CFR 58.81(c)SOPs: availability
- 21 CFR 58.83Reagents: outdated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NORTHEAST BIOLAB
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 5, 2025 | Not classified | New England District Office |
Other documents for NORTHEAST BIOLAB
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.